Statistics
Publications
4
Citations
53
H-Index
4
Active since
2022
Affiliations
Incyte (United States)(Current)
Qinda Ye is an author at Incyte (United States) specializing in drug design, antigen receptor signaling, and checkpoint inhibitor therapy.
Publications per year
2022–2025
4
4
Discovery of Pyrazolopyridine Derivatives as HPK1 Inhibitors
Qinda Ye, Kai Liu, Hai‐Fen Ye et al. · ACS Medicinal Chemistry Letters · 2022 · 14 citations · Full text
Discovery of INCB159020, an Orally Bioavailable KRAS G12D Inhibitor
Qinda Ye, Artem Shvartsbart, Zhenwu Li et al. · Journal of Medicinal Chemistry · 2025 · 12 citations
1–4 of 4